The roles of Cox17, Sco1 and Cox11 in copper metallation of CcO were substantiated by the observation that each protein is a Cu(I) binding protein and that mutations that abrogate in vivo function attenuate Cu(I) binding (11, (13) (14) (15) . Cox17 is a soluble proteins that localize within the IMS and also within the cytoplasm (8). The dual localization of Cox17 suggested that it served as a copper ion shuttle to the mitochondrion. However, we recently demonstrated that Cox17 is fully functional if tethered to the IM by a heterologous transmembrane domain (16) .
The pathway of copper ion delivery to CcO has not been resolved. Sco1 was proposed to mediate the transfer of Cu(I) ions from Cox17 to the Cu A site in Cox2 (17) . In support of this model is the observation that Sco1 and Cox2 interact (18) . Cox17 has not been shown to interact with any of these proteins, so its role as a copper donor to Sco1 and/or Cox11 remains unsubstantiated. Cox19, like Cox17, is a small soluble protein within the IMS, so it may also have a copper transfer function. However, nothing is known of which step in the CcO assembly is affected by Cox19.
Materials and Methods
Yeast strains. A wild-type W303 strain (MAT a, ade2-1, his3 -1,15, leu2,3,112, trp1-1, ura3-1) and isogenic cox17∆ variant (6) were used for all experiments. Yeast strains were cultured on plates or in liquid medium in either complete medium (CM) lacking uracil for pYEF2 selection and lacking leucine for pRS315 selection. Cells were cultured with glucose, raffinose or galactose as carbon sources as specified in the text. DNA transformations were performed using a lithium acetate protocol.
Plasmids. SCO1 corresponding to codons 95-296 fused to a 5' sequence encoding a His-purification tag was amplified from pTNDW4 (15) by PCR with NotI and EcoRI restriction sites added to the 5' and 3' ends, respectively. Likewise, mutant SCO1 encoding the same segment with the mutation (C 148 A,C 152 A) was amplified from pTNDW4-148,152 with NotI and EcoRI terminal sites. The truncated SCO1 genes were subcloned into pYEF2 containing the GAL1 promoter and CYC1 terminator for transformation of W303 cells (25) . The plasmid is designated YEp-GAL1-SCO1. A fusion of thioredoxin and COX11 lacking the first 300 base pairs of the ORF was PCR amplified from the pET32a vector pHCDW4 (11) and subcloned into pYEF2 creating plasmid YEp-GAL1-COX11. DNA encoding a Cox11 mutant with a triple alanine substitution of Cys111, Cys208 and Cys210 was amplified as a thioredoxin fusion from an existing mutant plasmid for subcloning into pYEF2. The construction of YCp-MET25-COX17 and YCp-MET25-SCO2/COX17 was described previously (16) . Maximum expression with the MET25 promoter occurs in medium lacking methionine, whereas minimal expression occurs in medium containing 0.67 mM methionine (5x the normal Met level). The Sco2/Cox17 fusion contains the 5'104 residues of Sco2 containing the N-terminal mitochondrial import sequence and transmembrane domain of Sco2 fused to Cox17. YEp-MET25-COX17-1 was constructed by insertion of COX17-1 encoding the C 57 Y variant of Cox17 in pRS426 (26) . The correct sequences of all plasmids generated in this study were confirmed by sequencing.
Protein purification. Recombinant Cox17 was purified as described previously (Heaton et al., 2001 ). E. coli BL21 (DE3) transformants with COX17 on a pAED3 vector were used for the (His-tagged SCO1 or mutant SCO1) as described previously (Nittis et al., 2001 ). The Sco1 molecules purified were soluble truncates lacking the N-terminal 95 residues that form the mitochondrial target sequence and transmembrane domain. Nickel-NTA Superflow (Qiagen) was used for the purification of the His-tagged Sco1 proteins. Apo-Sco1 was isolated from E. coli transformants induced in the absence of added copper to the growth medium. Under these conditions, Sco1 is recovered with less than 0.1 mol equiv. bound copper. E. coli strain BL21(DE3) harboring pHCDW4, a pET32a (Novagen) vector containing COX11 lacking the first 300 base pairs, was used for the purification of thioredoxin-Cox11 as a His-tagged fusion.
Ni-NTA (Qiagen) column chromatography was used as described previously (11). Apo-Cox11 was isolated from bacterial transformants induced in the absence of added copper to the growth medium. Yeast transformants with YEp-GAL1-SCO1 or YEp-GAL1-COX11 were cultured in raffinose medium to a OD 600nm of 0.6. Galactose was then added to induce expression of the His-tagged Sco1 or Cox11. Cells were harvested after 5 h for preparation of lysates by use of a French press and subsequent Ni-NTA purification from clarified samples. The overexpression of the soluble domain of Sco1 or Cox11 did not cause impaired mitochondrial respiration.
Copper transfer assay. For in vitro studies, CuCox17 and mutants were purified from E. coli, concentrated and stored anaerobically in 50 mM Tris pH 7.4, 100 mM NaCl, 1 mM dithiothreitol.
ApoSco1 or apoCox11 purified from E. coli were reduced in 50 mM dithiothreitol and subsequently desalted into transfer buffer (20 mM Tris-HCl pH 7.0, 100 mM NaCl). Assays. The copper concentration of the protein samples was measured using a Perkin Elmer (AAnalyst 100) atomic absorption spectrophotometer or a Perkin-Elmer Optima (3100XL) ICP spectrometer. Protein was quantified by amino acid analysis after hydrolysis in 5.7 N HCl at 110ºC in vacuo on a Beckman 6300 analyzer. Optical absorption spectroscopy was carried out on a Beckman DU640. Luminescence was measured on a Perkin Elmer LS55 fluorimeter with excitation set at 300 nm.
Westerns analysis. Protein (10-50 µg) from the mitochondrial or post-mitochondrial (cytosolic) fraction was electrophoresed on a 15% SDS-PAGE gel system and transferred to nitrocellulose (Bio-Rad Laboratories). Membranes were blocked in 1 X PBS (50 mM Na 2 PO 4 , 100 mM NaCl, Antisera to phosphoglycerate kinase (Pgk1) was from Molecular Probes. Chicken anti-yeast Cox11 antisera and rabbit anti-Sco1 antisera were generated as described previously (11, 15) .
Results
The luminescence of CuCox17 was used initially to monitor in vitro copper transfer to The concentration dependency of the copper transfer reactions was determined. Titrations using a fixed CuCox17 concentration and increasing the level of the apo-proteins to excess conditions revealed that only a subset of the Cox17-bound Cu is transferred to Sco1 as monitored by the CuCox17 emission (Fig. 3A, 3B ). Even after the addition of excess apo-Sco1, residual Cu(I) luminescence persisted in Cox17. Only approximately 40% of the Cox17-bound Cu(I) is transferred regardless of the excess of Sco1 used. The incomplete copper transfer from Cox17 arises from an inherent property within Cox17 and not Sco1. Doubling the Cox17 concentration doubles the amount of Sco1 that can be metallated. Concerning the metallation of Sco1, the nature of the titration curve suggests that copper transfer to Sco1 appears maximal near 1 mol eq. (Fig.   3A ). This observation is corroborated by recovery of Sco1, using the affinity tag, after a transfer reaction with limiting Sco1 levels. The resulting Sco1-bound copper content was near 1 mol equiv.
In a second series of titrations using excess Sco1 and varying the CuCox17 concentration, we observed a concentration dependency for copper transfer from Cox17 at limiting Cox17 levels ( Fig.   3B ). At concentrations below 10 µM Cox17, transfer to Sco1 appears impaired. One possibility is the known concentration-dependency in Cox17 oligomerization from dimers to tetramers (K D near 20 µM) (14). Dimeric Cox17 species may be less efficient than tetrameric species in the copper transfer reaction. Cox17 incubated in the presence and absence of apo-Sco1 was fractionated by gel filtration and the distribution of Cox17 oligomers was assessed by western analysis of the column fractions (Fig. 4A ). In the absence of Sco1, Cox17 was distributed in species representing tetramers, dimers and monomers as was shown previously (14) (Fig. 4B ). After incubation with apo-Sco1, less tetrameric Cox17 species were observed (Fig. 4B ).
Similar titrations of CuCox17 to apo-Cox11 revealed that only a subset of the Cox17-bound Cu was also transferred to Cox11 (Fig. 3A) . Approximately 55% of the Cox17-bound Cu(I) was transferred to Cox11. Mixtures of Sco1 and Cox11 did not result in greater depletion of Cox17-bound Cu(I) (data not shown). The stoichiometry of Cu(I) bound to Cox11 appeared to be 0.5 Cu(I) per monomer. Titration of Cox11 with varying CuCox17 concentrations showed more efficient copper transfer relative to Sco1 at lower Cox17 levels (Fig. 3B) . Cu binding to Cox11 appears to saturate in this assay at a copper stoichiometry near 0.5 mol equiv. This stoichiometry was confirmed by recovery of Cox11 using the affinity tag These in vitro studies suggested that Cox17 is a specific copper donor to both Sco1 and To determine whether Cox17 is a specific metallochaperone for Sco1, cells harboring the YEp-GAL1-SCO1 were transformed with a YCp vector containing COX17 under the control of the regulatable MET25 promoter. Overexpression of COX17 results in appreciable accumulation of Cox17 in the cytosol with a lesser increase in the IMS (8,13). His-tagged Sco1 was isolated from double transformants cultured in raffinose to an optical density of 0.5 followed by the addition of galactose for 5 h to induce SCO1. Sco1 recovered from these cells containing elevated levels of cytoplasmic Cox17 contained 1.0 mol equiv. copper (Fig. 5A) . Reduction of the COX17 expression by culturing the double transformants in high methionine still resulted in a copper content in the recovered Sco1 of 0.8 mol equiv. (data not shown). To ensure that the Sco1-bound copper was associated with the characterized Cu(I) site and not with the His-tag, the experiment was repeated using a double Sco1 mutant both cysteines in the CxxxC motif being replaced by alanine residues. In the absence of Cox17 over-expression, the copper content of the recovered Sco1 is 0.2 as mentioned, potentially due to low levels of endogenous, cytoplasmic Cox17. We did not test the metallation of Sco1 in cox17∆ cells as they grew poorly in raffinose medium. To test whether the limited Sco1-bound copper arose from endogenous cytoplasmic Cox17, we used cox17∆ cells containing a SCO2/COX17 chimeric protein. This chimera is functional and resides solely within the mitochondrial IM (16) . YEp-GAL1-SCO1 and YCp-ME25-SCO2/COX17 cotransformants were cultured in the usual conditions (raffinose followed by 5 h in galactose). Sco1 recovered from these cells had a copper content of <0.1 mol equiv. suggesting that copper ion metallation of Sco1 is dependent on the Cox17 protein under normal physiological growth conditions (Fig. 5A) .
The cytosolic assay was repeated using YEp-GAL1-COX11 transformants in the presence and absence of YCp-MET25-COX17. In the absence of co-expression of Cox17, Cox11 was recovered from yeast cytosol using Ni-NTA chromatography. The purity of the recovered Cox11 was insufficient for determination of the binding stoichiometry, so the samples were further purified by gel filtration on a S200 matrix. Purified Cox11 was recovered with 0.1 mol equiv. bound copper from cells cultured in synthetic medium without any supplemental copper (Fig. 5B) . Recovery of Cox11 from cells cultured in medium supplemented with 0.8 mM CuSO 4 resulted in 0.4 mol equiv.
copper bound. The protein eluted from the S200 gel filtration column in a volume consistent with a dimeric species. We reported previously that Cox11 purified from E. coli forms a stable dimer (11).
Co-expression of GAL1-COX11 and MET25-COX17 chimeric genes in cells cultured without supplemental copper results in enhanced copper metallation of Cox11 (Fig. 5B) . The copper content increased from 0.1 mol equiv. in the absence of Cox17 to nearly 0.5 in the presence of Cox17. This stoichiometry is 2-fold less than that observed when COX11 is expressed in E. coli cells cultured in copper-supplemented medium (11). The copper ions in the dimeric Cox11 purified from E. coli are closely spaced (11), so the repeated recovery of Cox11 from the yeast cytosol with only 0.5 mol equiv. bound copper may suggest a species exists with a single copper ion bound at the dimer interface. When a mutant Cox11 was induced in which Cys111, Cys208 and Cys210 were substituted by alanines, no appreciable copper binding was observed in the recovered protein (Fig. 5B) . Thus, copper binding by Cox11 is dependent on this Cys motif. Consistent with this result, we showed previously that recombinant Cox11 purified from E. coli as a thioredoxin fusion the observed Cu(I) binding was associated with Cox11 and not the thioredoxin (11). A double mutation of the two Cu(I) binding cysteine residues (15) . No co-purification was observed of Cox17 and the Sco1 mutant lacking the ability to bind Cu(I) (data not shown).
Discussion
Cox17 was postulated to function as a copper donor to Sco1 as an intermediate step in the copper metallation of the Cu A in Cox2 during assembly of cytochrome c oxidase (7,17, 29). This postulate was based on the suppression of the respiratory defect of a cox17∆ strain by overexpression SCO1 (7) and the fact that Sco1 is a copper-binding protein (15, 17) . In the present studies we directly confirm this postulate and extend the functional significance of Cox17 to show for the first time that it is also a copper donor to Cox11. Like Sco1, Cox11, is a copper-binding protein suggesting that copper metallation of Sco1 and Cox11 is an intermediate step in the transfer of copper to the Cu A site in Cox2 and Cu B site in Cox1, respectively (11).
Two assays were used to confirm the specificity of the Cox17-mediated copper transfer to Figure 5B 
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